{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:12:57Z","timestamp":1793052777930,"version":"4.5.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T00:00:00Z","timestamp":1384300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s10571-013-0002-0","type":"journal-article","created":{"date-parts":[[2013,11,12]],"date-time":"2013-11-12T07:34:15Z","timestamp":1384241655000},"page":"157-165","source":"Crossref","is-referenced-by-count":58,"title":["Neurological Damage in MSUD: The Role of Oxidative Stress"],"prefix":"10.1007","volume":"34","author":[{"given":"Angela","family":"Sitta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziela S.","family":"Ribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline P.","family":"Mescka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleth\u00e9a G.","family":"Barschak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moacir","family":"Wajner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen R.","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,13]]},"reference":[{"key":"2_CR1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/ars.2009.2668","volume":"12","author":"RM Adibhatla","year":"2010","unstructured":"Adibhatla RM, Hatcher JF (2010) Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 12:125\u2013169","journal-title":"Antioxid Redox Signal"},{"key":"2_CR2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S1472-6483(10)60920-0","volume":"8","author":"A Agarwal","year":"2004","unstructured":"Agarwal A, Said TM (2004) Carnitines and male infertility. Reprod Biomed Online 8:376\u2013384","journal-title":"Reprod Biomed Online"},{"key":"2_CR3","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1006\/exnr.1997.6550","volume":"146","author":"MY Aksenov","year":"1997","unstructured":"Aksenov MY, Aksenova MV, Payne RM, Smith CD, Markesbery WR, Carney JM (1997) The expression of creatine kinase isoenzymes in neocortex of patients with neurodegenerative disorders: Alzheimer\u2019s and Pick\u2019s disease. Exp Neurol 146:458\u2013465","journal-title":"Exp Neurol"},{"key":"2_CR4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nrn1434","volume":"10","author":"JK Andersen","year":"2004","unstructured":"Andersen JK (2004) Oxidative stress in neurodegeneration: cause or consequence? Nat Med 10:18\u201325","journal-title":"Nat Med"},{"key":"2_CR5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0197-0186(00)00100-5","volume":"38","author":"P Ara\u00fajo","year":"2001","unstructured":"Ara\u00fajo P, Wassermann GF, Tallini K et al (2001) Reduction of large neutral amino acid levels in plasma and brain of hyperleucinemic rats. Neurochem Int 38:529\u2013537","journal-title":"Neurochem Int"},{"issue":"6","key":"2_CR6","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0891-5849(89)90066-X","volume":"6","author":"OI Aruoma","year":"1989","unstructured":"Aruoma OI, Halliwell B, Hoey BM, Butler J (1989) The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 6(6):593\u2013597","journal-title":"Free Radic Biol Med"},{"key":"2_CR7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11011-006-9030-5","volume":"21","author":"AG Barschak","year":"2006","unstructured":"Barschak AG, Sitta A, Deon M et al (2006) Evidence that oxidative stress is increased in plasma from patients with maple syrup urine disease. Metab Brain Dis 21:279\u2013286","journal-title":"Metab Brain Dis"},{"key":"2_CR8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijdevneu.2007.05.004","volume":"25","author":"AG Barschak","year":"2007","unstructured":"Barschak AG, Sitta A, Deon M et al (2007) Erythrocyte glutathione peroxidase activity and plasma selenium concentration are reduced in maple syrup urine disease patients during treatment. Int J Dev Neurosci 25:335\u2013338","journal-title":"Int J Dev Neurosci"},{"key":"2_CR9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.clinbiochem.2007.11.015","volume":"41","author":"AG Barschak","year":"2008","unstructured":"Barschak AG, Marchesan C, Sitta A et al (2008a) Maple syrup urine disease in treated patients: biochemical and oxidative stress profiles. Clin Biochem 41:317\u2013324","journal-title":"Clin Biochem"},{"key":"2_CR10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11011-007-9077-y","volume":"23","author":"AG Barschak","year":"2008","unstructured":"Barschak AG, Sitta A, Deon M et al (2008b) Oxidative stress in plasma from maple syrup urine disease patients during treatment. Metab Brain Dis 23:71\u201380","journal-title":"Metab Brain Dis"},{"issue":"6","key":"2_CR11","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.clinbiochem.2008.12.005","volume":"42","author":"AG Barschak","year":"2009","unstructured":"Barschak AG, Sitta A, Deon M et al (2009) Amino acids levels and lipid peroxidation in maple syrup urine disease patients. Clin Biochem 42(6):462\u2013466","journal-title":"Clin Biochem"},{"key":"2_CR12","first-page":"191","volume":"20","author":"A Bertelli","year":"1994","unstructured":"Bertelli A, Conte A, Ronca G (1994) l-Propyonil carnitine protects erythrocytes and low density lipoproteins against peroxidation. Drugs Exp Clin Res 20:191\u2013197","journal-title":"Drugs Exp Clin Res"},{"key":"2_CR13","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1146\/annurev.bi.54.070185.004151","volume":"54","author":"SP Bessman","year":"1985","unstructured":"Bessman SP, Carpenter CL (1985) The creatine phosphate energy shuttle. Annu Rev Biochem 54:831\u2013862","journal-title":"Annu Rev Biochem"},{"key":"2_CR14","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1046\/j.1471-4159.1998.70030958.x","volume":"70","author":"EM Blanc","year":"1998","unstructured":"Blanc EM, Bruce-Keller AJ, Mattson MP (1998) Astrocytic gap junctional communication decreases neuronal vulnerability to oxidative stress-induced disruption of Ca2+ homeostasis and cell death. J Neurochem 70:958\u2013970","journal-title":"J Neurochem"},{"issue":"8","key":"2_CR15","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/BF00443107","volume":"148","author":"M Borglund","year":"1989","unstructured":"Borglund M, Sj\u00f6blad S, Akesson B (1989) Effect of selenium supplementation on the distribution of selenium among plasma proteins of a patient with maple syrup urine disease. Eur J Pediatr 148(8):767\u2013769","journal-title":"Eur J Pediatr"},{"key":"2_CR16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0736-5748(03)00074-1","volume":"21","author":"R Bridi","year":"2003","unstructured":"Bridi R, Araldi J, Sgarbi M et al (2003) Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease. Int J Dev Neurosci 21:327\u2013332","journal-title":"Int J Dev Neurosci"},{"key":"2_CR17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/10715760400022350","volume":"39","author":"R Bridi","year":"2005","unstructured":"Bridi R, Latini A, Braum CA et al (2005a) Evaluation of the mechanisms involved in leucine-induced oxidative damage in cerebral cortex of young rats. Free Radic Res 39:71\u201379","journal-title":"Free Radic Res"},{"key":"2_CR18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11011-005-4152-8","volume":"20","author":"R Bridi","year":"2005","unstructured":"Bridi R, Braun CA, Zorzi GK et al (2005b) \u03b1-Keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defenses in cerebral cortex from young rats. Metab Brain Dis 20:155\u2013167","journal-title":"Metab Brain Dis"},{"key":"2_CR19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jneumeth.2006.01.005","volume":"155","author":"R Bridi","year":"2006","unstructured":"Bridi R, Fontella FU, Pulronik V et al (2006) A chemically-induced acute model of maple syrup urine disease in rats for neurochemical studies. J Neurosci Methods 155:224\u2013230","journal-title":"J Neurosci Methods"},{"key":"2_CR20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0005-2728(99)00025-0","volume":"1411","author":"GC Brown","year":"1999","unstructured":"Brown GC (1999) Nitric oxide and mitochondrial respiration. Biochim Biophys Acta 1411:351\u2013369","journal-title":"Biochim Biophys Acta"},{"key":"2_CR21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3109\/10715769809065816","volume":"28","author":"E Cadenas","year":"1998","unstructured":"Cadenas E, Sies H (1998) The lag phase. Free Radic Res 28:601\u2013609","journal-title":"Free Radic Res"},{"key":"2_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399410001456","volume":"12","author":"IP Castro","year":"2010","unstructured":"Castro IP, Martins LM, Tufi R (2010) Mitochondrial quality control and neurological disease: an emerging connection. Exp Rev Mol Med 12:1\u201321","journal-title":"Exp Rev Mol Med"},{"key":"2_CR23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1152\/physrev.1979.59.3.527","volume":"59","author":"B Chance","year":"1979","unstructured":"Chance B, Sies H, Boveris A (1979) Hydroperoxide metabolism in mammalian organs. Physiol Rev 59:527\u2013605","journal-title":"Physiol Rev"},{"key":"2_CR24","volume-title":"The metabolic and molecular bases of inherited disease","author":"DT Chuang","year":"2001","unstructured":"Chuang DT, Shih VE (2001) Disorders of branched chain amino acid and keto acid metabolism. In: Scriver CR, Beaudet A, Sly WL, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York","edition":"8"},{"key":"2_CR25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0006-8993(00)03321-7","volume":"89","author":"AS Coitinho","year":"2001","unstructured":"Coitinho AS, de Mello CF, Lima TT, de Bastiani J, Fighera MR, Wajner M (2001) Pharmacological evidence that alpha-ketoisovaleric acid induces convulsions through GABAergic and glutamatergic mechanisms in rats. Brain Res 89:68\u201373","journal-title":"Brain Res"},{"key":"2_CR26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cca.2005.09.009","volume":"365","author":"MS Cooke","year":"2006","unstructured":"Cooke MS, Olinski R, Evans MD (2006) Does measurement of oxidative damage to DNA have clinical significance? Clin Chim Acta 365:30\u201349","journal-title":"Clin Chim Acta"},{"key":"2_CR27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijdevneu.2007.01.001","volume":"25","author":"PP Lima De","year":"2007","unstructured":"De Lima PP, Funchal C, Loureiro SO et al (2007) Branched-chain amino acids accumulating in maple syrup urine disease induce morphological alterations in C6 glioma cells probably through reactive species. Int J Dev Neurosci 25:181\u2013189","journal-title":"Int J Dev Neurosci"},{"key":"2_CR28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jns.2006.04.004","volume":"247","author":"M Deon","year":"2006","unstructured":"Deon M, Wajner M, Sirtori LR et al (2006) The effect of Lorenzo\u2032s oil on oxidative stress in X-linked adrenoleukodystrophy. J Neurol Sci 247:157\u2013164","journal-title":"J Neurol Sci"},{"key":"2_CR29","first-page":"595","volume":"55","author":"N Derin","year":"2004","unstructured":"Derin N, Izgut-Uysal VN, Agac A, Aliciguzel Y, Demir N (2004) l-Carnitine protects gastric mucosa by decreasing ischemia\u2013reperfusion induced lipid peroxidation. J Physiol Pharmacol 55:595\u2013606","journal-title":"J Physiol Pharmacol"},{"key":"2_CR30","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1357-2725(01)00046-2","volume":"33","author":"R Donato","year":"2001","unstructured":"Donato R (2001) S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33:637\u2013668","journal-title":"Int J Biochem Cell Biol"},{"key":"2_CR31","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/jemt.10296","volume":"60","author":"R Donato","year":"2003","unstructured":"Donato R (2003) Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 60:540\u2013551","journal-title":"Microsc Res Tech"},{"key":"2_CR32","first-page":"114","volume":"24","author":"RG Fariello","year":"1988","unstructured":"Fariello RG, Calabrese F (1988) Prevention of ischemia induced increase in MDA by acetyl carnitine. Ann Neurol 24:114\u2013118","journal-title":"Ann Neurol"},{"key":"2_CR33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1014004414733","volume":"17","author":"FU Fontella","year":"2002","unstructured":"Fontella FU, Gassen E, Pulronik V et al (2002) Stimulation of lipid peroxidation in vitro in rat brain by the metabolites accumulating in maple syrup urine disease. Metab Brain Dis 17:47\u201354","journal-title":"Metab Brain Dis"},{"key":"2_CR34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1749-6632.1999.tb07814.x","volume":"893","author":"I Fridovich","year":"1999","unstructured":"Fridovich I (1999) Fundamental aspects of reactive oxygen species, or what\u2019s the matter with oxygen? Ann N Y Acad Sci 893:13\u201318","journal-title":"Ann N Y Acad Sci"},{"key":"2_CR35","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.neuint.2006.05.007","volume":"49","author":"C Funchal","year":"2006","unstructured":"Funchal C, Latini A, Jacques-Silva MC et al (2006a) Morphological alterations and induction of oxidative stress in glial cells caused by the branched-chain alpha-keto acids accumulating in maple syrup urine disease. Neurochem Int 49:640\u2013650","journal-title":"Neurochem Int"},{"key":"2_CR36","first-page":"67","volume":"26","author":"C Funchal","year":"2006","unstructured":"Funchal C, Schuck PF, Santos AQ et al (2006b) Creatine and antioxidant treatment prevent the inhibition of creatine kinase activity and the morphological alterations of C6 glioma cells induced by the branched-chain alpha-keto acids accumulating in maple syrup urine disease. Cell Mol Neurobiol 26:67\u201379","journal-title":"Cell Mol Neurobiol"},{"key":"2_CR37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jns.2007.04.011","volume":"260","author":"C Funchal","year":"2007","unstructured":"Funchal C, Tramontina F, dos Santos AQ et al (2007) Effect of the branched-chain alpha-keto acids accumulating in maple syrup urine disease on S100B release from glial cells. J Neurol Sci 260:87\u201394","journal-title":"J Neurol Sci"},{"key":"2_CR38","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4612-5890-2","volume-title":"Oxygen and living processes: an interdisciplinary approach","author":"DL Gilbert","year":"1981","unstructured":"Gilbert DL (1981) Oxygen and living processes: an interdisciplinary approach, 1st edn. Springer, New York","edition":"1"},{"key":"2_CR39","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1074\/jbc.M707348200","volume":"283","author":"ME Greenberg","year":"2008","unstructured":"Greenberg ME, Li XM, Gugiu BG et al (2008) The lipid Whisker model of the structure of oxidized cell membranes. J Biol Chem 283:2385\u20132396","journal-title":"J Biol Chem"},{"key":"2_CR40","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.lfs.2005.05.103","volume":"78","author":"I Gulcin","year":"2006","unstructured":"Gulcin I (2006) Antioxidant and antiradical activities of l-carnitine. Life Sci 78:803\u2013811","journal-title":"Life Sci"},{"key":"2_CR41","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2165\/00002512-200118090-00004","volume":"18","author":"B Halliwell","year":"2001","unstructured":"Halliwell B (2001) Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18:685\u2013716","journal-title":"Drugs Aging"},{"key":"2_CR42","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1471-4159.2006.03907.x","volume":"97","author":"B Halliwell","year":"2006","unstructured":"Halliwell B (2006) Oxidative stress and neurodegeneration: where are we now? J Neurochem 97:1634\u20131658","journal-title":"J Neurochem"},{"key":"2_CR43","volume-title":"Free radicals in biology and medicine","author":"B Halliwell","year":"2007","unstructured":"Halliwell B, Gutteridge JMC (2007) Free radicals in biology and medicine, 4th edn. Clarendon Press, Oxford","edition":"4"},{"issue":"2","key":"2_CR44","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bbrc.2003.11.007","volume":"313","author":"RA Harris","year":"2004","unstructured":"Harris RA, Joshi M, Jeoung NH (2004) Mechanisms responsible for regulation of branched-chain amino acid catabolism. Biochem Biophys Res Commun 313(2):391\u2013396","journal-title":"Biochem Biophys Res Commun"},{"key":"2_CR45","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1212\/WNL.47.6_Suppl_3.161S","volume":"47","author":"P Jenner","year":"1996","unstructured":"Jenner P, Olanow CW (1996) Oxidative stress and the pathogenesis of Parkinson\u2019s disease. Neurology 47:161\u2013170","journal-title":"Neurology"},{"key":"2_CR46","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1091\/mbc.11.5.1919","volume":"11","author":"P Jouvet","year":"2000","unstructured":"Jouvet P, Rustin P, Taylor DL et al (2000) Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease. Mol Biol Cell 11:1919\u20131932","journal-title":"Mol Biol Cell"},{"issue":"1","key":"2_CR47","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1600-079X.2004.00177.x","volume":"38","author":"C Keithahn","year":"2005","unstructured":"Keithahn C, Lerchl A (2005) 5-Hydroxytryptophan is a more potent in vitro hydroxyl radical scavenger than melatonin or vitamin C. J Pineal Res 38(1):62\u201366","journal-title":"J Pineal Res"},{"key":"2_CR48","first-page":"763","volume":"33","author":"K Kremser","year":"1995","unstructured":"Kremser K, Stangl H, Pahan K, Singh I (1995) Nitric oxide regulates peroxisomal enzyme activities. Eur J Clin Chem Clin Biochem 33:763\u2013774","journal-title":"Eur J Clin Chem Clin Biochem"},{"issue":"26","key":"2_CR49","doi-asserted-by":"crossref","first-page":"15036","DOI":"10.1073\/pnas.93.26.15036","volume":"93","author":"RL Levine","year":"1996","unstructured":"Levine RL, Mosoni L, Berlett BS, Stadtman ER (1996) Methionine residues as endogenous antioxidants in proteins. Proc Natl Acad Sci USA 93(26):15036\u201315040","journal-title":"Proc Natl Acad Sci USA"},{"key":"2_CR50","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1096\/fasebj.13.15.2318","volume":"13","author":"D Liu","year":"1999","unstructured":"Liu D, Wen J, Liu J, Li L (1999) The roles of free radicals in amyotrophic lateral sclerosis: reactive oxygen species and elevated oxidation of protein, DNA, and membrane phospholipids. FASEB J 13:2318\u20132328","journal-title":"FASEB J"},{"key":"2_CR51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00445606","volume":"128","author":"I Lombeck","year":"1978","unstructured":"Lombeck I, Kasperek K, Harbisch HD et al (1978) The selenium state of children. II. Selenium content of serum, whole blood, hair and the activity of erythrocyte glutathione peroxidase in dietetically treated patients with phenylketonuria and maple-syrup-urine disease. Eur J Pediatr 128:213\u2013223","journal-title":"Eur J Pediatr"},{"key":"2_CR52","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0026-0495(95)90128-0","volume":"44","author":"S Lowitt","year":"1995","unstructured":"Lowitt S, Malone JI, Salem AF, Korthals J, Benford S (1995) Acetyl-l-carnitine corrects the altered peripheral nerve function of experimental diabetes. Metab Clin Exp 44:677\u2013680","journal-title":"Metab Clin Exp"},{"key":"2_CR53","first-page":"236","volume":"45","author":"I Matalliotakis","year":"2000","unstructured":"Matalliotakis I, Koumantaki Y, Evageliou A, Matalliotakis G, Goumenou A, Koumantakis E (2000) l-Carnitine levels in the seminal plasma of fertile and infertile men: correlation with sperm quality. Int J Fertil Womens Med 45:236\u2013240","journal-title":"Int J Fertil Womens Med"},{"key":"2_CR54","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0002-9343(00)00412-5","volume":"108","author":"JM McCord","year":"2000","unstructured":"McCord JM (2000) The evolution of free radicals and oxidative stress. Am J Med 108:652\u2013659","journal-title":"Am J Med"},{"key":"2_CR55","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11011-011-9238-x","volume":"26","author":"C Mescka","year":"2011","unstructured":"Mescka C, Moraes T, Rosa A et al (2011) In vivo neuroprotective effect of l-carnitine against oxidative stress in maple syrup urine disease. Metab Brain Dis 26:21\u201328","journal-title":"Metab Brain Dis"},{"key":"2_CR56","doi-asserted-by":"crossref","unstructured":"Mescka CP, Wayhs CA, Vanzin CS et al (2012) Protein and lipid damage in maple syrup urine disease patients: l-carnitine effect. Int J Dev Neurosci [Epub ahead of print]","DOI":"10.1016\/j.ijdevneu.2012.10.109"},{"key":"2_CR57","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1020731021276","volume":"16","author":"G Perry","year":"2003","unstructured":"Perry G, Taddeo MA, Petersen RB et al (2003) Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease. Biometals 16:77\u201381","journal-title":"Biometals"},{"key":"2_CR58","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1023\/A:1022876130038","volume":"28","author":"C Pilla","year":"2003","unstructured":"Pilla C, Cardozo RF, Dutra-Filho CS, Wyse AT, Wajner M, Wannmacher CM (2003) Creatine kinase activity from rat brain is inhibited by branched-chain amino acids in vitro. Neurochem Res 28:675\u2013679","journal-title":"Neurochem Res"},{"key":"2_CR59","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijdevneu.2010.01.002","volume":"28","author":"GS Ribas","year":"2010","unstructured":"Ribas GS, Manfredini V, de Mari JF et al (2010) Reduction of lipid and protein damage in patients with disorders of propionate metabolism under treatment: a possible protective role of l-carnitine supplementation. Int J Dev Neurosci 28:127\u2013132","journal-title":"Int J Dev Neurosci"},{"key":"2_CR60","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s11064-007-9423-9","volume":"33","author":"CA Ribeiro","year":"2008","unstructured":"Ribeiro CA, Sgaravatti AM, Rosa RB et al (2008) Inhibition of brain energy metabolism by the branched-chain amino acids accumulating in maple syrup urine disease. Neurochem Res 33:114\u2013124","journal-title":"Neurochem Res"},{"issue":"2","key":"2_CR61","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/01.CCM.0000109454.13145.CA","volume":"32","author":"C Ritter","year":"2004","unstructured":"Ritter C, Andrades ME, Reinke A, Menna-Barreto S, Moreira JC, Dal-Pizzol F (2004) Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis. Crit Care Med 32(2):342\u2013349","journal-title":"Crit Care Med"},{"issue":"1","key":"2_CR62","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bbr.2012.03.004","volume":"231","author":"G Scaini","year":"2012","unstructured":"Scaini G, Teodorak BP, Jeremias IC et al (2012a) Antioxidant administration prevents memory impairment in an animal model of maple syrup urine disease. Behav Brain Res 231(1):92\u201396","journal-title":"Behav Brain Res"},{"issue":"2","key":"2_CR63","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ymgme.2012.04.009","volume":"106","author":"G Scaini","year":"2012","unstructured":"Scaini G, Jeremias IC, Morais MO et al (2012b) DNA damage in an animal model of maple syrup urine disease. Mol Genet Metab 106(2):169\u2013174","journal-title":"Mol Genet Metab"},{"issue":"2","key":"2_CR64","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12035-012-8243-3","volume":"45","author":"G Scaini","year":"2012","unstructured":"Scaini G, de Rochi N, Jeremias IC et al (2012c) Evaluation of acetylcholinesterase in an animal model of maple syrup urine disease. Mol Neurobiol 45(2):279\u2013286","journal-title":"Mol Neurobiol"},{"key":"2_CR65","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jnutbio.2006.10.007","volume":"18","author":"HE Seifried","year":"2007","unstructured":"Seifried HE, Anderson DE, Fisher EI, Milner JA (2007) A review of the interaction among dietary antioxidants and reactive oxygen species. J Nutr Biochem 18:567\u2013579","journal-title":"J Nutr Biochem"},{"key":"2_CR66","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bbadis.2003.09.010","volume":"1639","author":"AM Sgaravatti","year":"2003","unstructured":"Sgaravatti AM, Rosa RB, Schuck PF et al (2003) Inhibition of brain energy metabolism by the alpha-keto acids accumulating in maple syrup urine disease. Biochim Biophys Acta 1639:232\u2013238","journal-title":"Biochim Biophys Acta"},{"key":"2_CR67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-642760-8.50005-3","volume-title":"Oxidative stress","author":"H Sies","year":"1985","unstructured":"Sies H (1985) Oxidative stress: introductory remarks. In: Sies H (ed) Oxidative stress, 1st edn. Academic Press, London, pp 1\u20137","edition":"1"},{"key":"2_CR68","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbadis.2005.02.005","volume":"1740","author":"LR Sirtori","year":"2005","unstructured":"Sirtori LR, Dutra-Filho CS, Fitarelli D et al (2005) Oxidative stress in patients with phenylketonuria. Biochim Biophys Acta 1740:68\u201373","journal-title":"Biochim Biophys Acta"},{"key":"2_CR69","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11011-006-9035-0","volume":"21","author":"A Sitta","year":"2006","unstructured":"Sitta A, Barschak AG, Deon M et al (2006) Investigation of oxidative stress parameters in treated phenylketonuric patients. Metab Brain Dis 21:287\u2013296","journal-title":"Metab Brain Dis"},{"key":"2_CR70","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mrgentox.2009.07.013","volume":"679","author":"A Sitta","year":"2009","unstructured":"Sitta A, Manfredini V, Biasi L et al (2009) Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients. Mutat Res 679:13\u201316","journal-title":"Mutat Res"},{"issue":"3","key":"2_CR71","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10571-010-9636-3","volume":"31","author":"A Sitta","year":"2011","unstructured":"Sitta A, Vanzin CS, Biancini GB et al (2011) Evidence that l-carnitine and selenium supplementation reduces oxidative stress in phenylketonuric patients. Cell Mol Neurobiol 31(3):429\u2013436","journal-title":"Cell Mol Neurobiol"},{"key":"2_CR72","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1542\/peds.34.4.454","volume":"34","author":"SE Snyderman","year":"1964","unstructured":"Snyderman SE, Norton PM, Roitman E (1964) Maple syrup urine disease with particular reference to diet therapy. Pediatrics 34:454\u2013472","journal-title":"Pediatrics"},{"issue":"4","key":"2_CR73","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/35067589","volume":"2","author":"H Soreq","year":"2001","unstructured":"Soreq H, Seidman S (2001) Acetylcholinesterase: new roles for an old actor. Nat Rev Neurosci 2(4):294\u2013302","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"2_CR74","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.abb.2003.10.001","volume":"423","author":"ER Stadtman","year":"2004","unstructured":"Stadtman ER (2004) Cyclic oxidation and reduction of methionine residues of proteins in antioxidant defense and cellular regulation. Arch Biochem Biophys 423(1):2\u20135","journal-title":"Arch Biochem Biophys"},{"key":"2_CR75","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11011-005-4147-5","volume":"20","author":"FM Stefanello","year":"2005","unstructured":"Stefanello FM, Franzon R, Tagliari B, Wannmaccher C, Wajner M, Wyse AT (2005) Reduction of butyrylcholinesterase activity in rat serum subjected to hyperhomocysteinemia. Metab Brain Dis 20:97\u2013103","journal-title":"Metab Brain Dis"},{"key":"2_CR76","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1023\/A:1023815119931","volume":"18","author":"EL Streck","year":"2003","unstructured":"Streck EL, Vieira PS, Wannmacher CM, Dutra-Filho CS, Wajner M, Wyse AT (2003) In vitro effect of homocysteine on some parameters of oxidative stress in rat hippocampus. Metab Brain Dis 18:147\u2013154","journal-title":"Metab Brain Dis"},{"key":"2_CR77","first-page":"109","volume":"53","author":"T Taketomi","year":"1983","unstructured":"Taketomi T, Kunishita T, Hara A, Mizushima S (1983) Abnormal protein and lipid compositions of the cerebral myelin of a patient with maple syrup urine disease. Jpn J Exp Med 53:109\u2013116","journal-title":"Jpn J Exp Med"},{"key":"2_CR78","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pneurobio.2004.02.001","volume":"72","author":"K Takuma","year":"2004","unstructured":"Takuma K, Baba A, Matsuda T (2004) Astrocyte apoptosis: implications for neuroprotection. Progr Neurobiol 72:111\u2013127","journal-title":"Progr Neurobiol"},{"key":"2_CR79","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.phrs.2007.07.008","volume":"56","author":"N Tastekin","year":"2007","unstructured":"Tastekin N, Aydogdu N, Dokmeci D et al (2007) Protective effects of l-carnitine and alpha-lipoic acid in rats with adjuvant arthritis. Pharmacol Res 56:303\u2013310","journal-title":"Pharmacol Res"},{"key":"2_CR80","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0022-510X(00)00402-0","volume":"181","author":"RG Tavares","year":"2000","unstructured":"Tavares RG, Santos CE, Tasca CI, Wajner M, Souza DO, Dutra-Filho CS (2000) Inhibition of glutamate uptake into synaptic vesicles of rat brain by the metabolites accumulating in maple syrup urine disease. J Neurol Sci 181:44\u201349","journal-title":"J Neurol Sci"},{"key":"2_CR81","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01800354","volume":"15","author":"E Treacy","year":"1992","unstructured":"Treacy E, Clow CL, Reade TR, Chitayat D, Mamer OA, Scriver CR (1992) Maple syrup urine disease: interrelations between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination. J Inherit Metab Dis 15:121\u2013135","journal-title":"J Inherit Metab Dis"},{"key":"2_CR82","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/0006-291X(83)90799-4","volume":"114","author":"D Tribble","year":"1983","unstructured":"Tribble D, Shapira R (1983) Myelin proteins: degradation in rat brain initiated by metabolites causative of maple syrup urine disease. Biochem Biophys Res Commun 114:440\u2013446","journal-title":"Biochem Biophys Res Commun"},{"key":"2_CR83","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbadis.2003.10.004","volume":"1688","author":"CR Vargas","year":"2004","unstructured":"Vargas CR, Wajner M, Sirtori LR et al (2004) Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy. Biochim Biophys Acta 1688:26\u201332","journal-title":"Biochim Biophys Acta"},{"key":"2_CR84","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1023\/B:BOLI.0000037353.13085.e2","volume":"27","author":"M Wajner","year":"2004","unstructured":"Wajner M, Latini A, Wyse AT, Dutra-Filho CS (2004) The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J Inherit Metab Dis 27:427\u2013448","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"2_CR85","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3177\/jnsv.48.36","volume":"48","author":"S Watanabe","year":"2002","unstructured":"Watanabe S, Togashi S, Takahashi N, Fukui T (2002) l-Tryptophan as an antioxidant in human placenta extract. J Nutr Sci Vitaminol (Tokyo) 48(1):36\u201339","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"2_CR86","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1023\/A:1027325620983","volume":"22","author":"HR Zielke","year":"1997","unstructured":"Zielke HR, Huang Y, Baab PJ, Collins RMJ, Zielke CL, Tildon JT (1997) Effect of alpha-ketoisocaproate and leucine on the in vivo oxidation of glutamate and glutamine in the rat brain. Neurochem Res 22:1159\u20131164","journal-title":"Neurochem Res"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-013-0002-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10571-013-0002-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-013-0002-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T02:46:43Z","timestamp":1647053203000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10571-013-0002-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,13]]},"references-count":86,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["2"],"URL":"https:\/\/doi.org\/10.1007\/s10571-013-0002-0","relation":{},"ISSN":["0272-4340","1573-6830"],"issn-type":[{"value":"0272-4340","type":"print"},{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,13]]}}}